Oncology Biomarkers: Global Markets
Report Scope:
This study provides a comprehensive analysis of oncology biomarkers on a global basis. It aims to offer a range of information, from detailed market analyses within cancer types to overall industry trends, to quantify and qualify the market for products and services in the oncology biomarkers segment. Current and projected market forecasts during the forecast period (2023 to 2028) are discussed. Figures for 2023 are estimated, except where actual results have been reported.
This report includes forecasts by biomarker type, cancer type, application, and region from 2023 through 2028. The report also includes an analysis of leading and emerging competitors in the current worldwide oncology biomarkers market. The competitive environment is examined with a particular focus on how new products and technologies influence the current standard of care.
Report Includes:
21 data tables and 60 additional tables
An in-depth analysis of the global oncology biomarkers market
Analyses of global market trends, with data from 2020, 2021, 2022, and projections of compound annual growth rates (CAGRs) through 2028
Characterization and quantification of biomarkers market by type, profiling technology, application, cancer type, and region
Discussion on market drivers, challenges and key market strategies and trends
Information on emerging products and technologies, new analytical platforms, novel immunoassays, and bioinformatics tools and discussion on the use of biomarkers in cancer drug development
Profiles of the competitive landscape with an overview of competitor growth strategies and opportunities
Company profiles of major players within the industry, including Abbott, F. Hoffmann-La Roche Ltd., Merck KGaA, Siemens Healthineers AG, and Thermo Fisher Scientific Inc.
- Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Methodology and Information Sources
- Geographic Breakdown
- Analyst’s Credentials
- BCC Custom Research
- Related BCC Research Reports
- Chapter 2 Summary and Highlights
- Chapter 3 Market Outlook
- Chapter 4 Market and Technology Background
- Overview of Biomarkers
- Classification of Biomarkers
- Types of Biomarkers
- Biomarker Discovery, Verification and Validation
- Overview of Cancer
- Cancer/Oncology Biomarkers
- Oncology Biomarkers Testing Methods
- Oncology Biomarkers Testing Types
- Biomarker Test Development and Marketing
- Chapter 5 Market Dynamics
- Drivers
- Rising Incidence of Cancer
- Increasing Use of Biomarkers in Drug Discovery and Development
- Developments in Analytical Technologies and Assay Methods
- Increased Availability and Ease of Biomarker Testing
- Support from Regulatory Agencies
- Barriers
- Inadequate Patient Access to and Insurance Coverage of Biomarker Testing
- Technical Errors and Delayed Test Results
- Low Provider and Patient Awareness
- Suboptimal Tissue Procurement and Triaging
- Shortages of Laboratories and Personnel
- Chapter 6 Market Breakdown by Biomarker Type
- Protein Biomarkers
- Protein Biomarkers Profiling Technologies
- Genomic Biomarker
- Genomic Biomarkers Profiling Technologies
- Other Biomarkers
- Metabolomic Biomarkers
- Cellular Biomarkers
- Global Market for Oncology Biomarkers, by Biomarker Type
- Protein Biomarkers
- Genomic Biomarkers
- Other Biomarkers
- Chapter 7 Market Breakdown by Application
- Life Science Research
- Risk Assessment and Screening
- Diagnostics
- Prognostics
- Therapeutic Selection and Clinical Trials
- Monitoring
- Response Monitoring
- Recurrence/Minimal Residual Disease (MRD) Monitoring
- Global Market for Oncology Biomarkers by Application
- Life Science Research
- Risk Assessment and Screening
- Diagnostics
- Prognostics
- Therapeutic Selection and Clinical Trials
- Monitoring
- Chapter 8 Market Breakdown by Cancer Type
- Market Overview
- Breast Cancer
- Lung Cancer
- Colorectal Cancer (CRC)
- Prostate Cancer
- Bladder Cancer
- Melanoma
- Leukemia
- Others
- Ovarian Cancer
- Liver Cancer
- Thyroid Cancer
- Cervical Cancer
- Kidney Cancer
- Endometrial Cancer
- Global Market for Oncology Biomarkers by Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Bladder Cancer
- Melanoma
- Leukemia
- Other Cancers
- Chapter 9 Market Breakdown by Region
- Global Market for Oncology Biomarkers by Region
- North America
- Market Revenue by Application
- Market Revenue by Country
- Europe
- Market Revenue by Application
- Market Revenue by Country
- Asia-Pacific
- Market Revenue by Application
- Market Revenue by Country
- Rest of World
- Market Revenue by Application
- Chapter 10 Impact of COVID-19
- Overview
- Implications on Cancer Diagnosis
- Implications on Cancer Treatment
- Impact on Oncology Biomarkers Market
- Chapter 11 Emerging Trends and Technologies in the Market
- Emerging Technologies and Trends in the Market
- Liquid Biopsy
- Circulating Free Nucleic Acids
- Circulating Cell-Free DNA (CfDNA)
- “Organ Agnostic” Biomarker Testing
- PD-L1
- Homologous Recombination Deficiency (HRD)
- Blood Test for Early-Stage Cancer Detection
- Chapter 12 Competitive Landscape
- Overview
- Mergers and Acquisitions
- SWOT Analysis for Global Oncology Biomarker Market
- Porter’s Five Forces Analysis of Global Oncology Biomarker Market
- Chapter 13 Company Profiles
- AGENDIA INC.
- ABBOTT
- AGILENT TECHNOLOGIES INC.
- BIOCARTIS NV
- BIOMERIEUX S.A.
- BIO-RAD LABORATORIES INC.
- BECTON, DICKINSON & CO.
- EXACT SCIENCES CORP.
- F. HOFFMANN-LA ROCHE AG
- GUARDANT HEALTH INC.
- HOLOGIC INC.
- ILLUMINA INC.
- LEICA BIOSYSTEMS
- MERCK KGAA
- MYRIAD GENETICS INC.
- QIAGEN N.V.
- SIEMENS HEALTHINEERS AG
- THERMO FISHER SCIENTIFIC INC.
- VERACYTE INC.
- Chapter 14 Appendix: Acronyms
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook